Skip to content

Nasdaq · CIK 0001725255

AHCO AdaptHealth Corp.

Insider trading from SEC Form 4. Last filing 32 d ago. Close $6.06 on Oct 9, 2026, +16% from the 52-week low and -55% from the high.

AdaptHealth Corp. (AHCO) has 50 SEC Form 4 filings on file from 20 insiders, the latest filed on Sep 11, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

11 open-market trades have been scored at AHCO. The newest: Russell E. Schuster III (Chief Commercial Officer) sold $113k of stock on Jun 1, 2026, filed Jun 3, 2026, scored 5 (weak), under a 10b5-1 plan. The largest of the 11 shown: Oep Vii Gp, L.l.c. (10% owner) bought $20M on Mar 10, 2026, scored 50 (moderate). 4 insiders bought within 14 days of each other around Mar 10, 2026.

AHCO closed at $6.06 on Oct 9, 2026, 16% above its 52-week low and 55% below its 52-week high.

6 Form 144 notices of planned sales are on file, the latest filed Jun 1, 2026.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
20
with a Form 4 at this company

Price and insider trades, last year

AHCOOct 9, 2026 · close 6.06

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at AdaptHealth Corp., scored.

ScoreInsiderValueHoldingsPrice contextFiled
5WeakRussell E. Schuster III
Chief Commercial Officer
sell
$113k
11,275 shares
-8%+20% from low-26% from high
50ModerateOep Vii Gp, L.l.c.
owner
buy
$20M
2,046,691 shares
+15%+32% from low-11% from high
45ModerateOep Vii Gp, L.l.c.
owner
buy
$4.4M
447,827 shares
+3%+38% from low-7% from high
45ModerateRichard M Cashin Jr
owner
buy
$4.4M
447,827 shares
+3%+38% from low-7% from high
50ModerateRichard M Cashin Jr
owner
buy
$20M
2,046,691 shares
+15%+32% from low-11% from high
45ModerateDale B Wolf
director
buy
$72k
8,000 shares
+8%+25% from low-20% from high
40ModerateRichard W. Rew II
CLO and General Counsel
buy
$45k
5,000 shares
+5%+24% from low-20% from high
21WeakDavid Solomon Williams III
director
sell
$47k
5,000 shares
-10%+28% from low-18% from high
29WeakDavid Solomon Williams III
director
sell
$80k
8,200 shares
-14%+31% from low-16% from high
37WeakJason A Clemens
Chief Financial Officer
sell
$327k
35,000 shares
-8%-
23WeakDale B Wolf
director
sell
$76k
7,000 shares
-9%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Jun 1, 2026 Schuster III Russell E.
Officer
11,275
0.01% of outstanding
$113kJun 1, 2026none
Dec 4, 2025 DAVID S WILLIAMS
Director
5,000
0.00% of outstanding
$47kDec 4, 2025none
Dec 19, 2024 Rietkerk Shaw
Officer
32,500
0.02% of outstanding
$315kDec 19, 2024$673k
Dec 10, 2024 JASON A CLEMENS &BIANCA S VITALE
Officer
35,000
0.03% of outstanding
$327kDec 10, 2024none
Nov 22, 2024 Rietkerk Shaw
Officer
40,000
0.03% of outstanding
$392kNov 22, 2024$281k
Nov 13, 2024 WOLF DALE B
Director
7,000
0.01% of outstanding
$75kNov 13, 2024none

Transactions

The newest 50 of 64 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 9, 2026Harriss T Currie
CHIEF FINANCIAL OFFICER
AGrant or award
Common Stock
+141,372$0.00$0141,37232 d ago
Jun 24, 2026Theodore B. Lundberg
director
AGrant or award
Common Stock
+18,999$0.00$0892,495Jun 26, 2026
Jun 24, 2026Susan T Weaver
director
AGrant or award
Common Stock
+18,999$0.00$040,345Jun 26, 2026
Jun 24, 2026David Solomon Williams III
director
AGrant or award
Common Stock
+18,999$0.00$064,044Jun 26, 2026
Jun 24, 2026Terence J Connors
director
AGrant or award
Common Stock
+18,999$0.00$095,262Jun 26, 2026
Jun 24, 2026Bradley J Coppens
director
AGrant or award
Common Stock
+18,999$0.00$096,345Jun 26, 2026
Jun 24, 2026Dale B Wolf
director
AGrant or award
Common Stock
+18,999$0.00$0123,234Jun 26, 2026
Jun 24, 2026Kenneth A Samet
director
AGrant or award
Common Stock
+18,999$0.00$018,999Jun 26, 2026
Jun 24, 2026Gregory Belinfanti
director
AGrant or award
Common Stock
+18,999$0.00$0104,269Jun 26, 2026
Jun 24, 2026Kenneth A Samet
director
AGrant or award
Common Stock
+6,070$9.89$60k25,069Jun 26, 2026
Jun 1, 2026Russell E. Schuster III
Chief Commercial Officer
SOpen-market sale
Common Stock10b5-1
-11,275$10.06$113k136,538Jun 3, 2026
May 27, 2026Daniel Edward McFadden
Chief Operating Officer
AGrant or award
Common Stock
+20,134$0.00$0103,376May 29, 2026
Mar 19, 2026Oep Vii Gp, L.l.c.
owner
POpen-market purchase
Common Stockindirect: See
+727$9.94$7,22815,865,598Mar 30, 2026
Mar 10, 2026Oep Vii Gp, L.l.c.
owner
POpen-market purchase
Common Stockindirect: See
+820,528$9.73$8.0M14,638,708Mar 30, 2026
Mar 11, 2026Oep Vii Gp, L.l.c.
owner
POpen-market purchase
Common Stockindirect: See
+536,827$9.73$5.2M15,175,535Mar 30, 2026
Mar 20, 2026Oep Vii Gp, L.l.c.
owner
POpen-market purchase
Common Stockindirect: See
+447,100$9.91$4.4M16,312,698Mar 30, 2026
Mar 12, 2026Oep Vii Gp, L.l.c.
owner
POpen-market purchase
Common Stockindirect: See
+689,336$9.73$6.7M15,864,871Mar 30, 2026
Mar 19, 2026Richard M Cashin Jr
owner
POpen-market purchase
Common Stockindirect: See footnotes
+727$9.94$7,22815,865,598Mar 23, 2026
Mar 20, 2026Richard M Cashin Jr
owner
POpen-market purchase
Common Stockindirect: See footnotes
+447,100$9.91$4.4M16,312,698Mar 23, 2026
Mar 13, 2026Albert A. Prast
Chief Technology Officer
MOption exercise
Common Stock
+89,451$4.38$392k532,358Mar 16, 2026
Mar 13, 2026Albert A. Prast
Chief Technology Officer
FTax withholding
Common Stock
-58,203$10.33$601k474,155Mar 16, 2026
Mar 13, 2026Albert A. Prast
Chief Technology Officer
MOption exercise
Employee Stock Option (right to buy)derivative
-89,451$0.00$00Mar 16, 2026
Mar 10, 2026Richard M Cashin Jr
owner
POpen-market purchase
Common Stockindirect: See footnotes
+820,528$9.73$8.0M14,638,708Mar 12, 2026
Mar 11, 2026Richard M Cashin Jr
owner
POpen-market purchase
Common Stockindirect: See footnotes
+536,827$9.73$5.2M15,175,535Mar 12, 2026
Mar 12, 2026Richard M Cashin Jr
owner
POpen-market purchase
Common Stockindirect: See footnotes
+689,336$9.73$6.7M15,864,871Mar 12, 2026
Mar 5, 2026Susan T Weaver
director
GGift
Common Stock
-73,472$0.00$021,346Mar 9, 2026
Mar 5, 2026Susan T Weaver
director
GGift
Common Stockindirect: By Irrevocable Trust
+73,472$0.00$073,472Mar 9, 2026
Feb 27, 2026Dale B Wolf
director
POpen-market purchase
Common Stock
+8,000$8.96$72k104,235Mar 3, 2026
Feb 26, 2026Richard W. Rew II
CLO and General Counsel
POpen-market purchase
Common Stock
+5,000$8.91$45k107,097Feb 27, 2026
Jan 30, 2026Suzanne Foster
Chief Executive Officer
AGrant or award
Common Stock
+329,449$0.00$0924,050Feb 3, 2026
Jan 30, 2026Daniel Edward McFadden
Chief Business Systems Officer
AGrant or award
Common Stock
+29,284$0.00$083,242Feb 3, 2026
Jan 30, 2026Albert A. Prast
Chief Technology Officer
AGrant or award
Common Stock
+63,449$0.00$0442,907Feb 3, 2026
Jan 30, 2026Toby Scott Barnhart
Chief Operating Officer
AGrant or award
Common Stock
+68,330$0.00$0220,654Feb 3, 2026
Jan 30, 2026Russell E. Schuster III
Chief Commercial Officer
AGrant or award
Common Stock
+48,807$0.00$0147,813Feb 3, 2026
Jan 30, 2026Richard W. Rew II
CLO and General Counsel
AGrant or award
Common Stock
+53,688$0.00$0102,097Feb 3, 2026
Jan 30, 2026Jason A Clemens
Chief Financial Officer
AGrant or award
Common Stock
+126,899$0.00$0673,481Feb 3, 2026
Jan 30, 2026Christine E. Archbold
Chief Accounting Officer
AGrant or award
Common Stock
+32,213$0.00$0107,198Feb 3, 2026
Jan 9, 2026Gregory Belinfanti
director
AGrant or award
Common Stock
+11,776$0.00$085,270Jan 13, 2026
Jan 9, 2026Theodore B. Lundberg
director
AGrant or award
Common Stock
+13,740$0.00$0873,496Jan 13, 2026
Dec 4, 2025David Solomon Williams III
director
SOpen-market sale
Common Stock
-5,000$9.43$47k45,045Dec 5, 2025
Aug 22, 2025David Solomon Williams III
director
SOpen-market sale
Common Stock
-8,200$9.73$80k50,045Aug 22, 2025
Jun 26, 2025Bradley J Coppens
director
AGrant or award
Common Stock
+21,346$0.00$077,346Jun 30, 2025
Jun 26, 2025Diana L Nole
director
AGrant or award
Common Stock
+21,346$0.00$033,045Jun 30, 2025
Jun 26, 2025David Solomon Williams III
director
AGrant or award
Common Stock
+21,346$0.00$058,245Jun 30, 2025
Jun 26, 2025Dale B Wolf
director
AGrant or award
Common Stock
+21,346$0.00$096,235Jun 30, 2025
Jun 26, 2025Gregory Belinfanti
director
AGrant or award
Common Stock
+21,346$0.00$066,754Jun 30, 2025
Jun 26, 2025Susan T Weaver
director
AGrant or award
Common Stock
+21,346$0.00$094,818Jun 30, 2025
Jun 26, 2025Terence J Connors
director
AGrant or award
Common Stock
+21,346$0.00$076,263Jun 30, 2025
Jun 26, 2025Theodore B. Lundberg
director
AGrant or award
Common Stock
+21,346$0.00$0851,892Jun 30, 2025
Jun 26, 2025Gregory Belinfanti
director
AGrant or award
Common Stock
+6,740$0.00$073,494Jun 30, 2025
50 of 64 rows shown.

Insiders

Everyone who has filed a Form 4 here.

Questions about AHCO

Answered from the filings on this page, as of the latest one.

Are insiders buying AHCO?

No. In the last 90 days no insider at AdaptHealth Corp. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade AHCO on the open market?

Russell E. Schuster III (Chief Commercial Officer) sold $113k of AHCO on Jun 1, 2026 and filed the Form 4 on Jun 3, 2026. InsiderTell scored 5 (weak), under a 10b5-1 plan.

How many insiders file Form 4 at AdaptHealth Corp.?

20 people have filed a Form 4 at AdaptHealth Corp., among them Christine E. Archbold (Chief Accounting Officer), Gregory Belinfanti (director), Toby Scott Barnhart (Chief Operating Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

AHCO insider trading: AdaptHealth Corp. | InsiderTell